Association Of Clinical Research Organizations
- Assets
- $3.4m
- Revenue
- $2.5m
- Investments
- $0.0
- Employees
- 0
- Location
- Washington, DC
- Founding
- 07/2002
- Data as of
- 12/2023
- EIN
- 02-0542064
Organization Overview
Association Of Clinical Research Organizations, operating under the name Acro, is located in Washington, DC. The organization was established in 2002. According to its NTEE Classification (S46) the organization is classified as: Boards of Trade, under the broad grouping of Community Improvement & Capacity Building and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Acro is a 501(c)(6) and as such, is described as a "Business League, Chambers of Commerce, or Real Estate Board" by the IRS.
For the year ending 12/2023, Acro generated $2.5m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 6.3% each year. All expenses for the organization totaled $2.1m during the year ending 12/2023. While expenses have increased by 5.1% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE O.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS (ACRO) REPRESENTS THE WORLD'S LEADING CLINICAL RESEARCH ORGANIZATIONS AND CLINICAL TECHNOLOGY COMPANIES. ACRO'S MEMBERS PROVIDE SPECIALIZED SERVICES THAT ARE INTEGRAL TO THE DEVELOPMENT OF DRUGS, BIOLOGICS, AND MEDICAL DEVICES. ACRO ADVANCES CLINICAL OUTSOURCING TO IMPROVE THE QUALITY, EFFICIENCY, AND SAFETY OF BIOMEDICAL RESEARCH. ACRO'S PRIORITIES IN 2023 INCLUDED: 1. A US FOCUS ON REGULATORY ADVOCACY, SPECIFICALLY REPRESENTING CLINICAL RESEARCH AND CLINICAL TECHNOLOGY COMPANIES IN POLICY DISCUSSIONS WITH THE FDA. (CONTINUED IN SCHEDULE O) 2. EU ADVOCACY FOCUSED ON REPRESENTING THE INDUSTRY IN POLICY DISCUSSIONS WITH THE EUROPEAN COMMISSION, THE EUROPEAN MEDICINES AGENCY, AND UK AND OTHER EU MEMBER STATE REGULATORY BODIES.3. REPRESENTING MEMBER COMPANIES TO OTHER REGULATORS AND INDUSTRY STAKEHOLDERS SUCH AS CUSTOMERS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Paul Kirchgraber Chair | OfficerTrustee | 1 | $0 |
Jackie Kent Past Chair (until Q3 2023) | OfficerTrustee | 1 | $0 |
Peyton Howell Vice-Chair | OfficerTrustee | 1 | $0 |
Steve Cutler Board Member (until Q3 2023) | Trustee | 1 | $0 |
Greg Licholai Board Member (as Of Q3 2023) | Trustee | 1 | $0 |
Cynthia Verst Board Member | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Washington Health Strategies Group Association Management And Lobbying Serv | 12/30/23 | $1,184,000 |
Beekeeper Group Llc Communications And Consulting Services | 12/30/23 | $255,986 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $2,375,000 |
| Investment income | $66,333 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $27,682 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $2,469,015 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $1,184,000 |
| Fees for services: Legal | $14,616 |
| Fees for services: Accounting | $22,298 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $11,289 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $37,440 |
| Travel | $35,980 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $166,735 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $4,010 |
| All other expenses | $39,834 |
| Total functional expenses | $2,091,418 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $413,725 |
| Savings and temporary cash investments | $354,452 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $75,000 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $10,729 |
| Net Land, buildings, and equipment | $34,850 |
| Investments—publicly traded securities | $2,537,693 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $3,426,449 |
| Accounts payable and accrued expenses | $55,128 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $55,128 |
| Net assets without donor restrictions | $3,371,321 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $3,426,449 |